Bristol Myers Squibb’s Psoriatic Arthritis Pill Shows Durable Efficacy After Two Years

기사 요약

Bristol Myers Squibb (BMY) 2-year Phase 3 data shows Sotyktu maintains durable efficacy and safety in active psoriatic arthritis.